Healthcare

SB 5713 creates new court procedures to protect patient anonymity in abortion-related legal cases and establishes civil penalties for healthcare providers who violate specific requirements for chemical abortions. It requires courts to seal records and issue orders preserving patient identity without consent, mandates lawsuits by specific parties (like patients or family members), and imposes $5,000 daily fines on providers for violations. Penalties collected fund pregnancy resource centers that do not perform or refer for abortions. The bill explicitly prohibits penalties against patients and clarifies definitions of "abortion-inducing drug" and "abortion pill provider."

HB 1413 prohibits Washington state agencies, counties, cities, and towns from purchasing opioid overdose reversal medications (commonly known as naloxone) from companies that have settled with states over claims of contributing to the opioid epidemic. The bill requires the Department of Health to maintain a public list of excluded entities and exempts companies already supplying these medications under pre-existing settlement agreements as of September 1, 2024. It directly affects government purchasers of naloxone by restricting their vendor options to distributors not linked to opioid settlement cases. The law aims to redirect procurement toward qualified distributors with no prior involvement in the opioid crisis.

HB 1038 prohibits licensed health care providers in Washington from prescribing puberty blockers, cross-sex hormones, or gender transition surgeries to minors (under 18) for the purpose of altering gender appearance or perception. Exceptions include treatment for medically verified disorders of sex development, tapering off existing medications, addressing complications from prior procedures, and emergency care for life-threatening conditions. The bill defines "minor" as under 18 and "sex" as biological characteristics present at birth (chromosomes, hormones, anatomy), excluding gender identity. It directly affects transgender and gender-diverse minors seeking these medical treatments, while allowing care for specific medical conditions. The bill is currently pending in the Health Care & Wellness committee after being prefaced in December 2024.

SB 5137 requires Washington public schools to obtain written approval from a child's parent or legal guardian before providing comprehensive sexual health education. This replaces the current system where parents could opt their child out with a written request, making parental consent mandatory prior to any instruction. The bill maintains existing curriculum requirements (including medically accurate, age-appropriate content covering abstinence, contraception, and affirmative consent) but shifts the process to require active parental approval. It directly affects parents/guardians of K-12 students in Washington public schools and takes effect starting the 2025-26 school year. The law amends RCW 28A.300.475 to formalize this approval requirement.